Story available to Subscribers Only

This story is presently only available to logged-in subscribers. Please login or contact sales@ctfn.news to learn about CTFN subscription options.



featured

Story available to Subscribers Only

This story is presently only available to logged-in subscribers. Please login or contact sales@ctfn.news to learn about CTFN subscription options.



featured

Market Definition Key in NxStage/Fresenius Merger Review

Market definition will be key in Germany-based Fresenius Medical Care’s $2 billion deal to acquire US-headquartered NxStage Medical, antitrustfeatured

Bayer Agreement with BASF Does Not Answer All EC Antitrust Issues

Last week BASF agreed to acquire significant parts of Bayer’s seed and non-selective herbicide businesses for $7 billion, but the deal does not answer all offeatured

AltaGas Faces Off with WGL Merger Critics

Opposition began to grow to AltaGas’s $6.4 billion acquisition of WGL Holdings as the Canadian natural gas company faced off this weekfeatured

CADE to Clear Time Warner/AT&T with Behavioral Remedies

Updated at 12:11pm EDT – The tribunal of Brazilian regulator CADE will approve the ongoing merger between AT&T and Time Warner with behavioralfeatured

Time Warner/AT&T Focus on Timing

With additional reporting by Valeria Camerino – An attorney for a public interest group that had sought to intervene in the Department of Justice’s review of thefeatured

Monsanto/Bayer Early Remedy Package Not Expected at European Commission

As the European Commission’s review of Bayer’s acquisition of Monsanto proceeds, Bayer is not planning to proactively offer remedies to the commission beyond thosefeatured

Monsanto and Bayer in Remedy Discussions with Indian Regulator

Monsanto and Bayer are in pre-phase 2 remedy negotiations with the Competition Commission of India, several antitrust sources familiarfeatured

Pace of State Approvals Picks Up in Genworth/China Oceanwide Deal

China Oceanwide’s purchase of Genworth Financial for $2.7 billion has faced a number of hurdles, including multiple state insurance department reviews, as well as an in-depth examinationfeatured

X

Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.